Weekly Market Outlook: BOC, BOJ, ECB and corporate earnings in focus
The Cult Of The Brave New Normal
Welsh People Blocked From Buying "Non-Essential" Items Due To Lockdown
Coca-Cola European Partners In Talks To Buy Australian Bottler – Report
Sweden Refuses To Impose New Lockdown Measures, Saying People Have Suffered Enough
AstraZeneca Gets FDA Nod To Resume US Covid-19 Trial
AstraZeneca, Oxford allowed to resume Covid-19 vaccine trial in U.S. – WSJ
The Destruction Of The Euro
Whose Great Reset? The Fight For Our Future – Technocracy Vs. The Republic
Double-Dip Recession Imminent (Or Did The First One Ever End?)
Week Ahead – The final stretch
Italy Reports Record Jump In COVID-19 Cases; New Jersey Sees Surge In ICU Occupancy: Live Updates
Real estate – The return of the living dead; well, for now
Free school meals: the lifelong impact of childhood food poverty
A year after Essex lorry deaths, UK-funded ads won't stop Vietnamese migrants risking their lives
The Bill From MMT: Higher Taxes, More Austerity, Rising Inflation Or Eventual Default
US Manufacturing Disappoints In Early October PMI Data As Election Anxiety Builds
Global Markets Rise Despite Fading Odds Of Stimulus Deal
World Reports Record Jump In COVID-19 Cases As Outbreak Explodes Across Europe, Midwest: Live Updates
Gilead’s remdesivir finally gets US approval
Macro Briefing: 23 October 2020
‘Mini-lungs’ reveal early stages of SARS-CoV-2 infection
How 'school streets' could create safer, healthier cities
Up to 40% of UK retail space is not needed – here's what can be done with it
Why lockdown had little to no effect on global temperatures
Futures Slide Ahead Of Final Debate, On Lack Of "Stimulus Optimism"
Blain: The Market Has No Memory
Pessimism floods European indices due to deterioration in German consumer confidence
Why optimism can be dangerous during a pandemic
AstraZeneca Covid-19 Brazil Trial To Continue After Volunteer Dies - Report